Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17274189 | 0.98 | ALDH1A1 (0.51) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL11204077 | 0.92 | LTA4H (0.47) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL3364133 | 0.90 | KCNA3 (0.52) | ALDH1A1RAB9ASMN1; SMN2PKMNPC1 | |
| SCHEMBL28319542 | 0.88 | TAAR1 (0.50) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL6451025 | 0.88 | ALDH1A1 (0.49) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL19846329 | 0.88 | ALDH1A1 (0.45) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL25737139 | 0.88 | ALDH1A1 (0.45) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL3459447 | 0.88 | KMT2A (0.47) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL6595731 | 0.88 | ALDH1A1 (0.45) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL14557453 | 0.88 | L3MBTL1 (0.55) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3207046-B1 | ACYCLIC CUCURBIT(N)URIL TYPE MOLECULAR CONTAINERS TO TREAT INTOXICATION AND DECREASE RELAPSE RATE IN SUBSTANCE ABUSE DISORDERS | UNIV MARYLAND (US) | 2024-09-25 | — | — | EP | disclosed |
| US-20240124476-A1 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | UNIVERSITY OF MARYLAND, COLLEGE PARK | 2024-04-18 | — | — | US | disclosed |
| US-11897893-B2 | Molecular containers and methods of making and using same | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2024-02-13 | — | — | US | disclosed |
| US-20210206774-A1 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | UNIVERSITY OF MARYLAND, COLLEGE PARK | 2021-07-08 | — | — | US | disclosed |
| US-9956229-B2 | Acyclic cucurbit[n]uril type molecular containers to treat intoxication and decrease relapse rate in substance abuse disorders | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2018-05-01 | — | — | US | disclosed |
| US-20170246180-A1 | ACYCLIC CUCURBIT[N]URIL TYPE MOLECULAR CONTAINERS TO TREAT INTOXICATION AND DECREASE RELAPSE RATE IN SUBSTANCE ABUSE DISORDERS | GENERAL HOSPITAL CORPORATION | 2017-08-31 | — | — | US | disclosed |
| EP-3207046-A1 | ACYCLIC CUCURBIT(N)URIL TYPE MOLECULAR CONTAINERS TO TREAT INTOXICATION AND DECREASE RELAPSE RATE IN SUBSTANCE ABUSE DISORDERS | University of Maryland, College Park (US) | 2017-08-23 | — | — | EP | disclosed |
| US-20170137431-A1 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | UNIVERSITY OF MARYLAND, COLLEGE PARK | 2017-05-18 | — | — | US | disclosed |
| US-9566351-B2 | Molecular containers and methods of making and using same | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2017-02-14 | — | — | US | disclosed |
| US-9567344-B2 | Molecular containers and methods of making and using same | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2017-02-14 | — | — | US | disclosed |
| US-9469648-B2 | Reversal of drug-induced neuromuscular block using novel molecular containers | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2016-10-18 | — | — | US | disclosed |
| WO-2016061571-A1 | ACYCLIC CUCURBIT(N)URIL TYPE MOLECULAR CONTAINERS TO TREAT INTOXICATION AND DECREASE RELAPSE RATE IN SUBSTANCE ABUSE DISORDERS | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2016-04-21 | — | — | WO | disclosed |
| EP-2627657-B1 | CUCURBIT[n]URIL-TYPE MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | UNIV MARYLAND (US) | 2016-02-03 | — | — | EP | disclosed |
| EP-2627641-B1 | REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK USING NOVEL CUCURBIT[n]URIL MOLECULAR CONTAINERS | UNIV MARYLAND (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20150328334-A1 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | UNIVERSITY OF MARYLAND | 2015-11-19 | — | — | US | disclosed |
| US-20130345273-A1 | REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK USING NOVEL MOLECULAR CONTAINERS | GENERAL HOSPITAL CORPORATION (US) | 2013-12-26 | — | — | US | disclosed |
| EP-2627641-A1 | REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK USING NOVEL MOLECULAR CONTAINERS | University of Maryland, College Park (US) | 2013-08-21 | — | — | EP | disclosed |
| EP-2627657-A2 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | University of Maryland, College Park (US) | 2013-08-21 | — | — | EP | disclosed |
| WO-2012051407-A2 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2012-04-19 | — | — | WO | disclosed |
| WO-2012051413-A1 | REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK USING NOVEL MOLECULAR CONTAINERS | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2012-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130345273-A1 | REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK USING NOVEL MOLECULAR CONTAINERS | CHRNA10, CHRNB4, CHRNA4 | ALDH1A1 2499/4885LMNA 702/4885POLB 2192/4885 |
| US-11897893-B2 | Molecular containers and methods of making and using same | CBR1, CNR1, CNR2 | ALDH1A1 466/4885LMNA 651/4885POLB 1502/4885 |
| US-20170137431-A1 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | CBR1, CNR1, CNR2 | ALDH1A1 466/4885LMNA 651/4885POLB 1502/4885 |
| US-20150328334-A1 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | CBR1, CNR1, CNR2 | ALDH1A1 466/4885LMNA 651/4885POLB 1502/4885 |
| US-20170246180-A1 | ACYCLIC CUCURBIT[N]URIL TYPE MOLECULAR CONTAINERS TO TREAT INTOXICATION AND DECREASE RELAPSE RATE IN SUBSTANCE ABUSE DISORDERS | CNR1, CNR2, OPRM1 | ALDH1A1 74/4885LMNA 3286/4885POLB 2720/4885 |
| US-20210206774-A1 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | CBR1, CNR1, CNR2 | ALDH1A1 466/4885LMNA 651/4885POLB 1502/4885 |
| US-20240124476-A1 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | CBR1, CNR1, CNR2 | ALDH1A1 466/4885LMNA 651/4885POLB 1502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.